EON Meditech Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: EON Meditech Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $211.3K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

EON Meditech Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $211.3K Trade | TransData Nexus

EON Meditech Private Limited

Indian Pharmaceutical Exporter · Medical Devices & Diagnostics Specialist · $211.3K Total Trade · DGFT Verified

EON Meditech Private Limited is an Indian pharmaceutical exporter with a total trade value of $211.3K across 2 products in 1 therapeutic categories. Based on 27 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Instrument ($202.3K), Catheter ($9.0K), .

EON Meditech Private Limited — Export Portfolio & Destination Treemap

EON Meditech Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is EON Meditech Private Limited? — Company Overview & Market Position

EON Meditech Private Limited, established on May 4, 2007, is a privately held company headquartered in Surat, Gujarat, India. The company specializes in the manufacturing of medical devices and diagnostics, focusing on finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. Its Corporate Identification Number (CIN) is U24232GJ2007PTC050742. The authorized capital stands at ₹1.70 million, with a paid-up capital of ₹0.10 million. As of April 6, 2024, EON Meditech employed 147 professionals. The company's registered office is located at 12, Gurukrupa Society, Opp Utran Arogya Kendra, Utran Road, Utran, Surat, Gujarat, 394105.

What Does EON Meditech Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Instrument$202.3K 2Catheter$9.0K

EON Meditech Private Limited Therapeutic Categories — 1 Specializations

Product Portfolio — Top 2 by Export Value

EON Meditech Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Instrument	Medical Devices & Diagnostics	$202.3K	24	14.8%	2
2	Catheter	Medical Devices & Diagnostics	$9.0K	3	8.4%	4

EON Meditech Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $211.3K. The top category is Medical Devices & Diagnostics (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

EON Meditech Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

EON Meditech operates manufacturing facilities in Surat, Gujarat, India. While specific details regarding plant capacities and specializations are not publicly disclosed, the company is known for producing high-quality medical devices and diagnostics, including finished pharmaceutical formulations. The manufacturing processes adhere to international standards, ensuring the production of reliable and effective medical products.

3Key Leadership

The leadership team at EON Meditech comprises:

Nirav Pravinbhai Khunt
Director since June 7, 2019.

Donasiya Manishkumar Bachubhai
Director since June 7, 2019.

Sandip Dhirajlal Savaliya
Director since May 4, 2007.

Naynaben Sandipbhai Savaliya
Director since March 26, 2012.

These individuals play pivotal roles in steering the company's strategic direction and operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does EON Meditech Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

EON Meditech's export activities, as per TransData Nexus proprietary trade data from 2022 to 2026, include:

Total Export Value: $211,000 USD
Total Shipments: 27
Products Exported: 2 across 1 therapeutic category
Top 5 Products:
Instrument: $202,000 (Rank #2, 14.8% market share)
Catheter: $9,000 (Rank #4, 8.4% market share)
Top 3 Categories: Medical Devices & Diagnostics (100.0%)

The company's portfolio is highly concentrated, with the top 5 products accounting for 100% of exports. However, specific details regarding regulatory filings, approvals, and market access status in the US, EU, UK, Australia, and Japan are not publicly available. This lack of information suggests that EON Meditech may not have established a significant presence in these regulated markets.

EON Meditech Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding EON Meditech's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. This lack of information suggests that the company may not have pursued FDA approvals for its products, potentially limiting its access to the US market.

2WHO & EU GMP

EON Meditech's export data does not indicate WHO prequalification or EU Good Manufacturing Practice (GMP) certifications. The absence of these certifications suggests that the company may not have pursued these accreditations, which are often essential for accessing certain international markets.

3CDSCO & Indian Regulatory

Specific details regarding EON Meditech's manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), approvals from state drug controllers, and export No Objection Certificates (NOCs) are not publicly available. This lack of information suggests that the company may not have pursued these regulatory approvals, potentially limiting its ability to export to certain countries.

EON Meditech Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

EON Meditech operates in the Medical Devices & Diagnostics sector, focusing on instruments and catheters. While specific competitors are not identified in the available data, the company's concentrated product portfolio may face competition from other manufacturers offering similar products. A detailed market analysis is recommended to identify key competitors and assess EON Meditech's competitive positioning.

2Key Differentiators

EON Meditech's commitment to innovation and affordability distinguishes it in the market. The company's focus on developing medical implants and biomedical instruments that meet international standards while maintaining cost-effectiveness appeals to a broad customer base.

3Strategic Position

EON Meditech's current strategic direction appears to be centered on the manufacturing of medical devices and diagnostics, particularly instruments and catheters. The company's export data indicates a concentrated product portfolio, suggesting a focus on specific product lines. Exploring opportunities in generics, specialty products, biosimilars, or Contract Development and Manufacturing Organizations (CDMO) could provide avenues for growth and diversification.

Buyer Due Diligence Brief — Evaluating EON Meditech Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

EON Meditech's export data indicates a total export value of $211,000 USD across 27 shipments, with instruments and catheters being the primary products. The company's portfolio is highly concentrated, with the top 5 products accounting for 100% of exports. The absence of diversification in product offerings may expose the company to risks associated with market fluctuations and regulatory changes. A comprehensive assessment of the company's supply chain, including supplier reliability and consistency, is recommended to ensure the quality and availability of products.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Approval: Confirm that the product is listed in the FDA's database of approved drugs.

WHO Prequalification: Check the WHO's list of prequalified products to ensure the product meets international standards.

Frequently Asked Questions — EON Meditech Private Limited

How many pharmaceutical products does EON Meditech Private Limited export from India?

EON Meditech Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Instrument ($202.3K), Catheter ($9.0K). Total export value is $211.3K.

What is EON Meditech Private Limited's total pharmaceutical export value?

EON Meditech Private Limited's total pharmaceutical export value is $211.3K, based on 27 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does EON Meditech Private Limited cover?

EON Meditech Private Limited exports across 1 therapeutic categories. The largest are Medical Devices & Diagnostics (100.0%, 2 products).

Get Full EON Meditech Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.